TapImmune, Inc. Aktie - TPIV

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

8,34

Gebot

7,06

Fragen

8,40

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

8,34

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing

TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing...

TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...

TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination...

TapImmune to Present at Two Upcoming Investor Conferences

TapImmune to Present at Two Upcoming Investor Conferences PR Newswire JACKSONVILLE, Fla., Sept. 25, 2018...

TapImmune To Present at 2018 Janney Healthcare Conference

TapImmune To Present at 2018 Janney Healthcare Conference PR Newswire JACKSONVILLE, Fla., Sept. 12, 2018...

TapImmune to Participate at Two Upcoming Industry Conferences

TapImmune to Participate at Two Upcoming Industry Conferences PR Newswire JACKSONVILLE, Fla., Aug. 29, 2018...

TapImmune Announces Pricing of $70 Million Private Placement

TapImmune Announces Pricing of $70 Million Private Placement Financing Led by New Enterprise Associates...

TapImmune to Present at the Jefferies 2018 Global Healthcare Conference

TapImmune to Present at the Jefferies 2018 Global Healthcare Conference PR Newswire JACKSONVILLE, Fla., May...

TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum

TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum PR...

TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics and Its Transfor...

TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics...

TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and Padmanee Sharma, ...

TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

TPIV - Frequently Asked Questions (FAQ)

What is the current TapImmune, Inc. share price?

The current share price of TapImmune, Inc. is US$ 8,34

What is the 1 year trading range for TapImmune, Inc. share price?

TapImmune, Inc. has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AREBAmerican Rebel Holdings Inc	US$ 6,275 (341,90%)	77,97M
IBGInnovation Beverage Group Limited	US$ 1,2502 (153,69%)	219,09M
SPWHSportsmans Warehouse Holdings Inc	US$ 1,91 (97,93%)	105,1M
JSPRWJasper Therapeutics Inc	US$ 0,13 (62,30%)	1,3k
TTECTTEC Holdings Inc	US$ 4,988 (52,54%)	17,19M
JYDJayud Global Logistics Ltd	US$ 0,347799 (-95,64%)	45,81M
RSLSReShape Lifesciences Inc	US$ 0,4501 (-71,69%)	73,88M
FLXBingEx Limited	US$ 2,245 (-56,96%)	722,98k
ICCTiCoreConnect Inc	US$ 2,22 (-52,97%)	12,58M
TBHBrag House Holdings Inc	US$ 0,7451 (-41,33%)	3,09M
DGLYDigital Ally Inc	US$ 0,0326 (25,38%)	1,23B
DMNDamon Inc	US$ 0,0136 (13,33%)	831,02M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 11,2813 (10,49%)	369,34M
LGMKLogicMark Inc	US$ 0,018399 (-5,16%)	259,36M
NVDANVIDIA Corporation	US$ 110,42 (0,25%)	220,56M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Marker Therapeutics (delisted) (TPIV)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

TPIV Neueste Nachrichten

TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing

TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...

TapImmune to Present at Two Upcoming Investor Conferences

TapImmune To Present at 2018 Janney Healthcare Conference

TapImmune to Participate at Two Upcoming Industry Conferences

TapImmune Announces Pricing of $70 Million Private Placement

TapImmune to Present at the Jefferies 2018 Global Healthcare Conference

TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum

TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics and Its Transfor...

TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and Padmanee Sharma, ...

TPIV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Marker Therapeutics (delisted) (TPIV) Börsenkurse

Marker Therapeutics (delisted) (TPIV)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

TPIV Neueste Nachrichten

TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing

TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...

TapImmune to Present at Two Upcoming Investor Conferences

TapImmune To Present at 2018 Janney Healthcare Conference

TapImmune to Participate at Two Upcoming Industry Conferences

TapImmune Announces Pricing of $70 Million Private Placement

TapImmune to Present at the Jefferies 2018 Global Healthcare Conference

TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum

TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics and Its Transfor...

TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and Padmanee Sharma, ...

TPIV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS